Maryland researchers find that otter poop can tell important information about the ecosystem
A new study from the Smithsonian Environmental Research Center in Edgewater, Maryland, found that otter poop, or "scat," serves as a natural report card for the ecosystem.
A team of scientists at the Smithsonian Environmental Research Center spent the past few years collecting and studying otter poop from these latrines along the Rhode River.
Their study, published last week, found otter scat contains important clues about what's going on in our waterways.
"As an apex predator and a disease sentinel, river otters can serve as a sort of an indicator of the health of the ecosystem and if things are or are not going well," said Calli Wise, the lead author of the study.
By testing the droppings, researchers found that otters are eating fish and a lot of crustaceans, along with smaller mammals and birds, most importantly parasites.
"The fact that river otters eat so many parasites is actually really important for the health of the ecosystem, and the people that rely on this ecosystem for a living."
Wise says parasites help balance the food chain, and because otters live both on land and in water, the parasites in their prey can be an early warning system for environmental changes.
"Seeing if that changes over time can be a flag, a signal to people when things are going well or poorly in the water," Wise said.
Otters can even warn of potential risks to humans.
"Those would be things that we'd look at as indicators of poor water quality or sewage or other things in the water column."
The team hopes their findings will aid restoration efforts in the future.
"It's been really fun to see otters popping up in more urban spaces and see people get excited about conservation related to this species."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Here's why NASA wants your photos of hurricane damage
NASA is launching a pilot program to harness citizen science for faster hurricane disaster recovery. The space agency, in collaboration with the Global Learning and Observations to Benefit the Environment (GLOBE) Program, a science and education initiative, is spearheading a new Response Mapper project. This innovative initiative will utilize photographs submitted by the public, both before and after a disaster, to track ground conditions in affected areas. Throughout the summer and fall, NASA is actively encouraging public participation in the program, especially from residents in the Southeast, the region most often devastated by tropical storms, hurricanes, and related flooding. 'Your contributions could ultimately help emergency managers make faster and better-informed decisions when it matters most and strengthen your community's ability to respond and recover from disasters,' NASA said. These time-stamped and geotagged images will be shared directly with emergency responders, complementing existing data from satellites and field reports, according to the space agency. Disaster response teams often face challenges when obtaining "clear, localized" information, especially in rural areas, NASA said. Satellite imagery offers a broad view of hazards but may overlook short-lived impacts due to factors such as cloud cover, timing of the orbit, or data processing delays. Satellites can also overlook finer details that photos taken closer to the ground could capture. 'We're exploring how citizen science can support disaster response in ways that Earth observation data alone can't,' said Kristen Okorn, a coordinator for NASA's Disasters Response Coordination System, in a statement. 'A single photo of land cover, whether it is a flooded street, fallen trees, or even an undamaged area, can offer helpful context.' Such photos can be combined with other observations to help verify the situation on the ground, determining where cleanup crews are needed or assessing other impacts such as crop losses or potential further threats to public safety. Citizens can share photos by downloading the GLOBE Observer app on their smartphones and joining the NASA Response Mappers team. The agency stresses that there is an inherent risk during hurricane season and members of the public should never put themselves in danger to take photos, particularly when collecting data in the midst of or immediately after a severe storm. Data collection is requested in areas of the south and southeast United States, including the states of Texas, Louisiana, Mississippi, Alabama, Tennessee, Kentucky, Georgia, Florida, North Carolina, South Carolina, and Virginia, as well as Puerto Rico and the U.S. Virgin Islands.
Yahoo
43 minutes ago
- Yahoo
Artemis 2 astronauts suit up for nighttime moon launch dress rehearsal (photos, video)
When you buy through links on our articles, Future and its syndication partners may earn a commission. The next astronauts headed to the moon are preparing for all contingencies as their mission approaches, and they recently completed a nighttime rehearsal of launch procedures. NASA's Artemis 2 mission — the first-ever crewed mission of the Orion capsule and Space Launch System (SLS) — is targeting a liftoff between February and April of 2026. Aboard Orion will be NASA astronauts Reid Wiseman, Victor Glover and Christina Koch, and Canadian Space Agency (CSA) astronaut Jeremy Hansen. The quartet will fly Orion on a journey around the moon, looping around the natural satellite and slingshotting back to Earth on a "free-return" trajectory. The Artemis 2 crew practiced nighttime launch protocols during a recent dress rehearsal at NASA's Kennedy Space Center (KSC) in Florida, during which they donned their spacesuits to review emergency egress procedures on the launch tower. Beginning on Aug. 12, the Artemis 2 astronauts spent about two nights going through the motions of putting on their spacesuits inside KSC's Neil Armstrong Operations and Checkout Building (O&C), for different launch day scenarios around the Launch Complex-39B (LC-39B) pad and nearby Vehicle Assembly Building (VAB), where the Artemis 2 SLS rocket is currently being stacked on its mobile launcher. One exercise had the crew run through a launch scrub sequence, driving the 9 miles (14.5 kilometers) from O&C to LC-39B, and then back to O&C to gauge routes, communications and timing. The Artemis 2 crew also practiced emergency egress procedures in the VAB's High Bay 3, the site of the SLS stacking. In the event of a launch day emergency in which the Artemis 2 crew is already inside Orion or near the top of the launch tower, a rapid exit that puts as much distance as possible between the rocket and the astronauts is necessary to ensure their safety. In these cases, crews board cable trolley baskets secured at the top of the mobile launch platform (MLP), which transport them to the perimeter of LC-39B's "pad terminus area," according to a NASA blog post. Those baskets are currently on the floor of the VAB, where the MLP and SLS are also currently being housed — about 3 miles (5 km) from LC-39B. To complete their emergency egress simulation, the astronauts traveled between both sites. Moving from O&C to the VAB in full spacesuit attire, the Artemis 2 astronauts ascended the MLP tower to the White Room, the connection area at the end of the MLP crew access arm that opens to Orion's hatch. Back on the VAB floor, the crew practiced entering and exiting the emergency egress baskets. From there, the crew were transported to the LC-39B perimeter, where the baskets would carry them during an actual launch day emergency. Whisked inside armored response vehicles, the Artemis 2 crew were then driven to predetermined safe zones around KSC before the test was concluded. Last week's nighttime dress rehearsal closely mirrors a daytime run-through that the crew completed in 2023. Since then, their mission has been delayed several times, kicking the goal post from 2024 to its current NET (no earlier than) date of February 2026 (though the crew says April is more likely). NASA released highlights from the most recent launch day simulation, following the crew from suit-up, transport, ascent and descent of the launch tower to the cable baskets, and out to the launch pad. That full video is available below: Related Stories: — NASA's Artemis Program: Live updates — NASA's Artemis 2 Orion spacecraft fuels up and moves closer to launch — Fly me to the moon: 25 finalists chosen for Artemis 2 'zero-g indicator' NASA's first Artemis mission launched an uncrewed Orion on a month-long mission to lunar orbit at the end of 2022. Damage to Orion's heat shield after reentry through Earth's atmosphere and other issues have delayed the program's second mission to 2026. Artemis 3 is slated to fly NET 2027 and will be the first mission to land astronauts back on the surface of the moon since the end of the Apollo era more than 50 years ago. NASA has tapped SpaceX's Starship rocket as that mission's lunar lander. Starship is facing development delays of its own, threatening further delays if the vehicle isn't ready on NASA's timeline. Solve the daily Crossword
Medscape
an hour ago
- Medscape
TNF Inhibitor Use in Pregnancy Shows a Growing Trend in US
TOPLINE: TNF inhibitors were used by 64% of pregnant women with inflammatory diseases through all trimesters. Those with continuous use through all trimesters had reduced use of corticosteroids postpartum. METHODOLOGY: Researchers analyzed prescriptions of TNF inhibitors in pregnant women with chronic inflammatory diseases in the MarketScan US commercial claims database, focusing on usage patterns and discontinuation compared with those who continued using them throughout pregnancy. They included live birth pregnancies among women aged 15-45 years with rheumatoid arthritis, radiographic axial spondyloarthritis, psoriatic arthritis, psoriasis, and/or inflammatory bowel disease who were hospitalized between 2011 and 2021. A total of 3711 pregnancies were exposed to TNF inhibitors during gestation, with use of TNF inhibitors defined as having at least one filled prescription or infusion during the preconception, gestation, or postpartum periods. The time of exposure during pregnancy was categorized by trimesters, with a grace period of five half-lives added to account for biologic activity. TNF inhibitors were classified by high or low placental transfer ability, using national drug and procedure codes. The use of systemic corticosteroids and nonbiologic disease-modifying antirheumatic drugs was also assessed. TAKEAWAY: Overall, 64% of pregnancies were exposed to TNF inhibitors throughout all trimesters, whereas 17% were exposed during a single trimester and 18% during two trimesters. Additionally, 89% had preconception exposure, and 68% had postpartum exposure. Among pregnant women with inflammatory bowel disease, 84% continued using TNF inhibitors throughout all trimesters. A higher proportion of pregnant women with rheumatoid arthritis, psoriatic arthritis, and radiographic axial spondyloarthritis/psoriasis discontinued TNF inhibitors before the third trimester than those with inflammatory bowel disease. The proportion of pregnancies exposed to TNF inhibitors throughout all trimesters increased from 55% in 2011-2013 to 73% in 2020-2021 (P for trend < .001). Pregnancies with continuous use of TNF inhibitors had lower use of corticosteroids during pregnancy and postpartum than those with limited exposure. Exposure to TNF inhibitors with a high placental transfer ability was seen in 73% of pregnancies, whereas exposure to low-transfer agents was seen in 27%; switching from high- to low-transfer TNF inhibitors occurred in 1.4% of pregnancies, with 0.2% switching from low- to high-transfer agents. IN PRACTICE: 'Our findings suggest a trend toward increased TNFi [inhibitor] continuation throughout gestation. As TNFi continue to be widely used, ongoing evaluation of their safety and long-term outcomes during pregnancy will be critical, notably related to immunization response in offspring. This information will inform future guidelines and help optimize the health of mothers with chronic inflammatory disease and their children,' the authors of the study concluded. SOURCE: This study was led by Leah K. Flatman, PhD, McGill University, Montreal, Quebec, Canada. It was published online on June 15, 2025, in The Journal of Rheumatology. LIMITATIONS: The study's retrospective design may lead to residual confounding because it relied on administrative data. The lack of detailed clinical information, such as disease activity levels and reasons for stopping TNF inhibitors, limited the understanding of treatment decisions. Potential misclassification of TNF inhibitor exposure and gestational timing exists owing to reliance on claims data. The exclusion of stillbirths limits the generalizability of findings, and the focus on commercially insured women may not reflect broader populations. DISCLOSURES: This study was funded by the Canadian Institutes of Health Research (CIHR) project grant and the Arthritis Society Stars Career Development Award to an author who also reported receiving senior salary support from the Fonds de Recherche du Québec — Santé. Another author received support from a CIHR Canada Graduate Scholarships Doctoral Award. No relevant conflicts of interest were disclosed by the authors. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
